US Food and Drug Administration FDA Guidance Provides New Details on Diversity Action Plans Required for Certain Clinical Studies
Today, the U.S. Food and Drug Administration issued a draft guidance, “Diversity Action Plans to Improve Enrollment of Participants from ...












